D.E. Shaw & Co’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

D.E. Shaw & Co’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-953,465	Closed	-$25.9M	–	4041
2015 Q4	$25.9M	Buy	953,465 +230,998	+32%	+$5.95M	0.04%	529
2015 Q3	$15.8M	Sell	722,467 -83,255	-10%	-$2.12M	0.02%	722
2015 Q2	$23M	Buy	805,722 +60,312	+8%	+$1.76M	0.03%	592
2015 Q1	$20.4M	Buy	745,410 +351,402	+89%	+$9.68M	0.03%	590
2014 Q4	$10.4M	Buy	394,008 +347,708	+751%	+$10.2M	0.01%	1083
2014 Q3	$1.4M	Buy	+46,300	New	+$1.43M	﹤0.01%	2528
2014 Q2	–	Sell	-45,439	Closed	-$1.47M	–	4806
2014 Q1	$1.47M	Buy	+45,439	New	+$1.59M	﹤0.01%	2684
2013 Q4	–	Sell	-6,832	Closed	-$266K	–	4860
2013 Q3	$266K	Buy	+6,832	New	+$275K	﹤0.01%	3951

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

D.E. Shaw & Co's MR Position: Q1 2016 in Review

D.E. Shaw & Co sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 953,465 shares — an estimated $25.9M sold.

D.E. Shaw & Co first reported a position in MR in Q3 2013 and held it in 8 quarters. The position peaked at $25.9M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

D.E. Shaw & Co reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
D.E. Shaw & Co sold 953,465 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $25.9M.
D.E. Shaw & Co first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2013 and held it in 8 quarters.
D.E. Shaw & Co's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $25.9M in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.